Sheena Bhalla, M.D.

Harold C. Simmons Comprehensive Cancer Center

Internal Medicine - Hematology/Oncology
Lung Cancer
Thoracic malignancies

New Patient Appointment Accepting Virtual Visits or 214-645-4673

Biography

Sheena Bhalla, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer, mesothelioma, and thymoma.

Dr. Bhalla earned her medical degree at the University of Florida College of Medicine. She completed a residency in internal medicine at the Icahn School of Medicine at Mount Sinai, where she also gained advanced training through a hematology and medical oncology fellowship.

Certified by the American Board of Internal Medicine in Medical Oncology and Hematology, she joined the UT Southwestern faculty in 2021.

Dr. Bhalla is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the International Association for the Study of Lung Cancer.

She has published numerous articles in her key areas of research, which include lung cancer, clinical trials, and cancer care delivery.

Education & Training

Residency - Icahn School of Medicine at Mount Sinai (2015-2018), Internal Medicine
Medical School - University of Florida College of Medicine (2011-2015)
Fellowship - Icahn School of Medicine at Mount Sinai (2018-2021), Hematology Oncology

Professional Associations & Affiliations

American Association for Cancer Research
American Society of Clinical Oncology
International Association for the Study of Lung Cancer

Honors & Awards

Chief Fellow, Hematology & Medical Oncology 2020-2021, Icahn School of Medicine at Mount Sinai
Student Teaching Award 2017, Icahn School of Medicine at Mount Sinai
Alpha Omega Alpha Honor Medical Society 2015
William Osler Award in Internal Medicine 2015, University of Florida College of Medicine
Bythewood & Baker Memorial Scholarship Award for Women Medical Students 2014, University of Florida College of Medicine

Books & Publications

Publications
- Care disruptions among patients with lung cancer: A COVID-19 and cancer outcomes study.
  Bhalla S, Bakouny Z, Schmidt AL, Labaki C, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, El Zarif T, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB, Lung cancer (Amsterdam, Netherlands) 2021 Jul 160 78-83
- PD-L1 as a biomarker of response to immune-checkpoint inhibitors.
  Doroshow DB, Bhalla S, Beasley MB, Sholl LM, Kerr KM, Gnjatic S, Wistuba II, Rimm DL, Tsao MS, Hirsch FR, Nature reviews. Clinical oncology 2021 06 18 6 345-362
- Impact of pathological response after neoadjuvant chemotherapy on adjuvant therapy decisions and patient outcomes in gastrointestinal cancers.
  Bhalla S, Zhu H, Lin JY, Özbek U, Wilck EJ, Chang S, Chen X, Ward S, Harpaz N, Polydorides AD, Miller W, Fiel MI, Modica I, Fan W, Zeizafoun N, Ang C, Cancer reports (Hoboken, N.J.) 2021 May e1412
- Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study.
  Schmidt AL, Bakouny Z, Bhalla S, Steinharter JA, Tremblay DA, Awad MM, Kessler AJ, Haddad RI, Evans M, Busser F, Wotman M, Curran CR, Zimmerman BS, Bouchard G, Jun T, Nuzzo PV, Qin Q, Hirsch L, Feld J, Kelleher KM, Seidman D, Huang HH, Anderson-Keightly HM, Abou Alaiwi S, Rosenbloom TD, Stewart PS, Galsky MD, Choueiri TK, Doroshow DB, Cancer cell 2020 Dec 38 6 769-770
- Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19.
  Naymagon L, Zubizarreta N, Feld J, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Christian K, Mascarenhas J, Dembitzer F, Moshier E, Tremblay D, Thrombosis research 2020 12 196 99-105
- Predictive Biomarkers for Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Current Status and Future Directions.
  Bhalla S, Doroshow DB, Hirsch FR, Cancer journal (Sudbury, Mass.) 2020 Nov/Dec 26 6 507-516
- Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients.
  Tremblay D, Seah C, Schneider T, Bhalla S, Feld J, Naymagon L, Wang B, Patel V, Jun T, Jandl T, Rahman F, Liu STH, Aberg JA, Bouvier N, Cancer medicine 2020 11 9 22 8571-8578
- Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19.
  Thibaud S, Tremblay D, Bhalla S, Zimmerman B, Sigel K, Gabrilove J, British journal of haematology 2020 07 190 2 e73-e76
- Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.
  Tremblay D, van Gerwen M, Alsen M, Thibaud S, Kessler A, Venugopal S, Makki I, Qin Q, Dharmapuri S, Jun T, Bhalla S, Berwick S, Feld J, Mascarenhas J, Troy K, Cromwell C, Dunn A, Oh WK, Naymagon L, Blood 2020 Jul 136 1 144-147
- Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia.
  Kamath GR, Tremblay D, Coltoff A, Caro J, Lancman G, Bhalla S, Najfeld V, Mascarenhas J, Taioli E, Carcinogenesis 2019 07 40 5 651-660
- Differences in the clinical and genetic profile of Hispanic and non-Hispanic acute myeloid leukemia patients.
  Kamath GR, Tremblay D, Coltoff A, Caro J, Lancman G, Bhalla S, Najfeld V, Mascarenhas J, Taioli E, Leukemia research 2019 02 77 1-4
- Implications of Mutation Profiling in Myeloid Malignancies-PART 2: Myeloproliferative Neoplasms and Other Myeloid Malignancies.
  Sokol K, Tremblay D, Bhalla S, Rampal R, Mascarenhas JO, Oncology (Williston Park, N.Y.) 2018 05 32 5 e45-e51
- Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia.
  Tremblay D, Sokol K, Bhalla S, Rampal R, Mascarenhas JO, Oncology (Williston Park, N.Y.) 2018 04 32 4 e38-e44
- Discontinuing Tyrosine Kinase Inhibitor Therapy in Chronic Myelogenous Leukemia: Current Understanding and Future Directions.
  Bhalla S, Tremblay D, Mascarenhas J, Clinical lymphoma, myeloma & leukemia 2016 09 16 9 488-494
- Long-term follow-up for efficacy and safety of treatment of retinitis pigmentosa with valproic acid.
  Bhalla S, Joshi D, Bhullar S, Kasuga D, Park Y, Kay CN, The British journal of ophthalmology 2013 Jul 97 7 895-9

Research

Biomarker-driven clinical trials in lung cancer
Novel therapeutics and therapeutic combinations in lung cancer
Cancer care delivery

Clinical Focus

Lung Cancer
Thoracic malignancies
Mesothelioma